Paragon [FNA] vs Novocure [NVCR] Detailed Stock Comparison
Paragon
NYSE
Loading...
Novocure
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Paragon wins in 11 metrics, Novocure wins in 6 metrics, with 0 ties. Paragon appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Paragon | Novocure | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | -7.62 | N/A |
| Price-to-Book Ratio | 8.41 | 3.86 | Novocure |
| Debt-to-Equity Ratio | 86.22 | 200.39 | Paragon |
| PEG Ratio | -27.85 | -0.47 | Paragon |
| EV/EBITDA | -52.91 | -7.16 | Paragon |
| Profit Margin (TTM) | -21.33% | -27.13% | Paragon |
| Operating Margin (TTM) | -8.97% | -24.89% | Paragon |
| Return on Equity | -36.39% | -48.07% | Paragon |
| Return on Assets (TTM) | -8.18% | -8.64% | Paragon |
| Free Cash Flow (TTM) | $-44.10M | $-69.22M | Paragon |
| 1-Year Return | 33.57% | -33.91% | Paragon |
| Price-to-Sales Ratio (TTM) | 4.29 | 2.14 | Novocure |
| Enterprise Value | $1.18B | $1.14B | Paragon |
| EV/Revenue Ratio | 4.59 | 1.81 | Novocure |
| Gross Profit Margin (TTM) | 72.92% | 73.88% | Novocure |
| Revenue per Share (TTM) | $3 | $6 | Novocure |
| Earnings per Share (Diluted) | $-0.66 | $-1.56 | Paragon |
| Beta (Stock Volatility) | 1.47 | 0.61 | Novocure |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Paragon vs Novocure Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Paragon | 0.00% | 0.54% | 0.61% | 20.31% | 138.00% | 22.11% |
| Novocure | 1.10% | 2.76% | -26.02% | -32.90% | -46.08% | -60.29% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Paragon | 33.57% | -29.09% | -30.04% | -30.04% | -30.04% | -30.04% |
| Novocure | -33.91% | -85.61% | -85.48% | -34.85% | -34.85% | -34.85% |
Performance & Financial Health Analysis: Paragon vs Novocure
| Metric | FNA | NVCR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.10B | $1.35B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,859,637 | 1,472,920 |
| 90 Day Avg. Volume | 2,418,279 | 1,826,717 |
| Last Close | $13.09 | $11.91 |
| 52 Week Range | $4.65 - $13.13 | $10.87 - $34.13 |
| % from 52W High | -0.30% | -65.10% |
| All-Time High | $25.41 (Nov 08, 2021) | $232.76 (Jun 21, 2021) |
| % from All-Time High | -48.48% | -94.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.06% |
| Quarterly Earnings Growth | 0.18% | 0.06% |
| Financial Health | ||
| Profit Margin (TTM) | -0.21% | -0.27% |
| Operating Margin (TTM) | -0.09% | -0.25% |
| Return on Equity (TTM) | -0.36% | -0.48% |
| Debt to Equity (MRQ) | 86.22 | 200.39 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.56 | $3.13 |
| Cash per Share (MRQ) | $0.41 | $8.15 |
| Operating Cash Flow (TTM) | $-27,148,000 | $-44,676,000 |
| Levered Free Cash Flow (TTM) | $-22,887,124 | $5.94M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Paragon vs Novocure
| Metric | FNA | NVCR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | -7.62 |
| Forward P/E | -27.85 | -8.05 |
| PEG Ratio | -27.85 | -0.47 |
| Price to Sales (TTM) | 4.29 | 2.14 |
| Price to Book (MRQ) | 8.41 | 3.86 |
| Market Capitalization | ||
| Market Capitalization | $1.10B | $1.35B |
| Enterprise Value | $1.18B | $1.14B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.59 | 1.81 |
| Enterprise to EBITDA | -52.91 | -7.16 |
| Risk & Other Metrics | ||
| Beta | 1.47 | 0.61 |
| Book Value per Share (MRQ) | $1.56 | $3.13 |
Financial Statements Comparison: Paragon vs Novocure
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FNA | NVCR |
|---|---|---|
| Revenue/Sales | $71.75M | $154.99M |
| Cost of Goods Sold | $19.43M | $38.52M |
| Gross Profit | $52.32M | $116.47M |
| Research & Development | $6.74M | $53.78M |
| Operating Income (EBIT) | $-6.43M | $-37.87M |
| EBITDA | $-2.63M | $-34.54M |
| Pre-Tax Income | $-10.56M | $-30.30M |
| Income Tax | $558,000 | $4.02M |
| Net Income (Profit) | $-11.12M | $-34.32M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FNA | NVCR |
|---|---|---|
| Cash & Equivalents | $34.58M | $127.28M |
| Total Current Assets | $168.85M | $1.09B |
| Total Current Liabilities | $48.13M | $743.31M |
| Long-Term Debt | $110.05M | $137.76M |
| Total Shareholders Equity | $130.59M | $361.96M |
| Retained Earnings | $-178.29M | $-1.19B |
| Property, Plant & Equipment | $73.83M | $145.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FNA | NVCR |
|---|---|---|
| Operating Cash Flow | $-7.00M | $-14.80M |
| Capital Expenditures | $-2.34M | $-10.61M |
| Free Cash Flow | $-6.23M | $-46.28M |
| Debt Repayment | $-160,000 | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FNA | NVCR |
|---|---|---|
| Shares Short | 1.07M | 5.22M |
| Short Ratio | 0.64 | 3.09 |
| Short % of Float | 0.02% | 0.07% |
| Average Daily Volume (10 Day) | 4,859,637 | 1,472,920 |
| Average Daily Volume (90 Day) | 2,418,279 | 1,826,717 |
| Shares Outstanding | 83.86M | 108.52M |
| Float Shares | 44.19M | 94.15M |
| % Held by Insiders | 0.31% | 0.10% |
| % Held by Institutions | 0.51% | 0.86% |
Dividend Analysis & Yield Comparison: Paragon vs Novocure
| Metric | FNA | NVCR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |